The Evidence Library

The complete evidence library

360 source-led articles across the foundations, practice, measurement, and frontier of healthy longevity.

Every article states a bottom line, links claims to qualified sources, marks uncertainty, and provides a correction path. Deep synthesis is available in Reports. Reviewed August 12, 2026.

Jump to: Healthy Aging Foundations · Movement & Strength · Nutrition & Metabolic Health · Sleep & Recovery · Brain & Mental Wellbeing · Prevention & Care · Biology of Aging · Measure What Matters · Emerging Longevity Science · Evidence Literacy

Start here

Healthy Aging Foundations

The durable, high-confidence ideas that matter more than longevity hype.

18 evidence articles

  1. Healthy Aging Is More Than Adding Years
    A useful definition of longevity protects function, participation, and wellbeing—not just survival.
  2. Healthspan and Lifespan: The Difference That Changes the Goal
    Why the quality and independence of later years deserve as much attention as their number.
  3. The High-Confidence Core of Healthy Longevity
    The least glamorous actions have the deepest and most transferable evidence base.
  4. Why Consistency Usually Beats Optimization
    Health behaviors work through repetition; precision matters less when the routine never happens.
  5. Function Is a Health Signal, Not a Character Test
    Strength, walking, balance, and daily tasks can reveal change without defining a person’s worth.
  6. Social Connection Belongs in a Longevity Plan
    Connection is not a soft extra; it is part of health, meaning, and practical resilience.
  7. Sleep Is Infrastructure, Not Lost Time
    Sleep supports daytime function, yet more time in bed is not automatically better sleep.
  8. Preventive Care Is a Conversation, Not a Universal Checklist
    Good prevention matches evidence to age, history, preferences, prior testing, and competing risks.
  9. Risk Reduction Is Not Risk Elimination
    Healthy choices can shift probabilities; they cannot make biology predictable or blameproof.
  10. Build a Personal Healthspan Dashboard Without the Hype
    A small set of meaningful trends can be more useful than dozens of unvalidated scores.
  11. Frailty Is a Dynamic Risk State, Not a Synonym for Old Age
    Frailty describes reduced reserve and greater vulnerability to stressors. It can improve, worsen, or fluctuate, and multicomponent exercise has the strongest intervention signal.
  12. Oral Health Is Functional Health—Without the Systemic-Disease Hype
    Teeth, gums, saliva, dentures, pain, and access to care affect eating, speaking, comfort, and social life; observational links to distant diseases should not overshadow these direct benefits.
  13. Air Pollution Is a Longevity Risk You Cannot Supplement Away
    Fine particles and other pollutants contribute to cardiovascular, respiratory, cerebrovascular, metabolic, and cancer burden, with older adults and disadvantaged communities carrying disproportionate risk.
  14. Extreme Heat Is a Medication and Aging Risk—Make the Plan Before the Alert
    Older physiology, chronic disease, social isolation, limited cooling, and common medications can converge during hot weather; a written plan is more reliable than improvising when symptoms begin.
  15. Advance Care Planning: A Conversation and a Trusted Person, Not Just a Form
    Planning for future medical decisions can protect autonomy when illness or injury makes communication impossible, but documents work only when people can find and interpret them.
  16. Sexual Health After Cancer: Ask, Assess, and Treat the Specific Problem
    Cancer and treatment can affect desire, arousal, erection, lubrication, orgasm, pain, body image, fertility, continence, relationships, and intimacy. Silence is a care failure, not evidence that the issue is unimportant.
  17. Post-Intensive Care Syndrome: Survival Can Leave Physical, Cognitive, and Emotional Injury
    After critical illness, new or worsened weakness, cognitive impairment, anxiety, depression, post-traumatic stress, sleep problems, and caregiver strain can persist together. Recovery is variable and rarely belongs to one specialty.
  18. Recovery After Sepsis: Track the Long Tail, Not Only the Infection
    Sepsis survival can be followed by recurrent infection, organ dysfunction, weakness, cognitive change, mood symptoms, medication disruption, and readmission. Some problems reflect critical illness; others reveal the condition that caused it.

Open the focused topic page →

Build capacity

Movement & Strength

Activity, strength, balance, mobility, and the evidence behind staying capable.

33 evidence articles

  1. How Much Physical Activity Do Adults Need?
    The guideline is a range and a direction of travel—not an all-or-nothing entrance exam.
  2. Why Strength Training Belongs in Healthy Aging
    Strength supports daily life, and older muscle remains responsive to training.
  3. Two Strength Days Can Be a Serious Program
    A compact routine can meet the public-health standard and produce meaningful adaptation.
  4. One Set, Three Sets, or More? Reading the Volume Evidence
    Volume matters, but the relationship is not a simple contest to do the most work.
  5. Strength Training and Bone: Promise With Boundaries
    Resistance and weight-bearing exercise can support bone, but bone response is site-specific and slower than strength gains.
  6. Balance Training Is Specific—and Worth Practicing
    Walking is valuable, but it does not fully replace practice that deliberately challenges balance.
  7. Walking Is Powerful—and Not the Whole Program
    Walking is accessible aerobic activity; strength, balance, and higher-intensity capacity may need separate attention.
  8. Sit Less Without Turning Sitting Into a Sin
    Long sedentary periods are a modifiable exposure, but rest and seated activity are normal parts of life.
  9. Resistance Exercise With Heart Disease: A Team Decision
    Cardiovascular disease does not automatically rule out strength training, but screening and program design matter.
  10. Start Strength Training Without Chasing Soreness
    Soreness is a possible side effect, not the goal or a reliable score of an effective session.
  11. Sarcopenia Is More Than Low Muscle Mass
    Modern consensus places weakness and poor physical performance near the center because muscle quantity alone does not reliably identify who will lose mobility or suffer adverse outcomes.
  12. Fall Prevention Works Best as Training Plus a Personal Risk Review
    Structured exercise has the most consistent preventive evidence, while medication, vision, blood-pressure, footwear, and home risks determine what else belongs in an individual plan.
  13. Exercise After Cancer: Proven Functional Benefits and a Landmark Colon-Cancer Trial
    Exercise improves fatigue, function, and quality of life across survivorship; CHALLENGE now provides phase 3 evidence for disease-free survival after adjuvant treatment for resected colon cancer, with boundaries that matter.
  14. Knee Osteoarthritis: Exercise Is Core Treatment, Not Joint Damage
    Osteoarthritis pain is real, but ordinary progressive exercise does not wear away the knee. Strength, aerobic work, skill, weight decisions, braces, and medicines can be combined around function.
  15. Chronic Low Back Pain: Build Capacity and Avoid the Imaging Trap
    Most persistent low back pain is managed through education, activity, exercise, selected physical or psychological approaches, and careful medicine use—not repeated imaging or passive treatment alone.
  16. Chronic Dizziness: Diagnose the Pattern, Then Use Vestibular Rehabilitation Selectively
    Dizziness can mean spinning, faintness, imbalance, visual motion sensitivity, or nonspecific disorientation. Timing, triggers, examination, medicines, and neurologic signs matter more than the word alone.
  17. Urinary Incontinence in Women: Identify the Type Before Choosing Pelvic Floor Training
    Stress leakage, urgency, overflow, mobility barriers, infection, medicines, and neurologic disease need different responses. Pelvic floor muscle training is effective conservative care, but correct contraction and an individualized plan matter.
  18. Exercise With Parkinson's Disease: Train Specific Functions, Not a Cure Narrative
    Aerobic, resistance, balance, gait, cueing, and task-specific practice can improve meaningful Parkinson outcomes. The program should match symptoms, medication cycles, cognition, falls, and personal goals.
  19. Stroke Rehabilitation: Recovery Is Task-Specific, Multidisciplinary, and Still Possible Later
    Stroke recovery involves impairment, activity, and participation. Coordinated rehabilitation combines repeated meaningful practice with medical prevention, communication, cognition, mood, caregiver, and environmental support.
  20. Cardiac Rehabilitation: The Prescription After the Procedure
    Cardiac rehabilitation combines assessed exercise, risk-factor treatment, medication support, nutrition, tobacco care, psychosocial support, and education after qualifying cardiovascular events and procedures.
  21. Pulmonary Rehabilitation: Train the Person, Not Just the Lungs
    Pulmonary rehabilitation combines exercise training, education, self-management, and behavior change for chronic respiratory disease. Breathlessness is a reason to assess and adapt training, not automatically to avoid movement.
  22. Cancer-Related Fatigue: Assess the Drivers Before Prescribing More Rest
    Cancer fatigue is persistent physical, cognitive, or emotional exhaustion disproportionate to activity and not fully relieved by rest. It can arise during treatment or persist long afterward.
  23. Cancer-Related Lymphedema: Detect Early, Compress Precisely, Keep Moving
    Damage or obstruction of lymphatic drainage can cause chronic limb, genital, trunk, head, or neck swelling after cancer or its treatment, sometimes years later. Early assessment can limit progression and protect function.
  24. Exercise During and After Cancer: Prescribe Around the Treatment, Not the Diagnosis Alone
    Exercise can improve fatigue, physical function, quality of life, anxiety, depression, strength, and fitness across many cancer settings, but the safe prescription depends on treatment, blood counts, bone, nerves, heart, wounds, infection, and baseline capacity.
  25. Prehabilitation Before Major Surgery: Build Reserve Without Promising Protection
    Prehabilitation tries to improve physical, nutritional, psychological, and practical reserve before surgery. The idea is compelling, but programs, operations, populations, adherence, and outcomes differ enough that benefit cannot be assumed.
  26. Hip Fracture Recovery: Treat the Fracture and the Whole Emergency
    A hip fracture is simultaneously an orthopedic injury, acute medical stress, mobility emergency, delirium risk, and warning of future fracture. Delay, immobility, poor pain control, and fragmented follow-up can compound the injury.
  27. Hospital Mobility: Bed Rest Is a Dose With Side Effects
    Older adults can lose walking and self-care capacity during an admission even when the acute disease improves. Mobility needs an explicit order, safety assessment, adequate assistance, and repeated practice across the day.
  28. Choosing Post-Acute Rehabilitation: Match the Setting to the Work of Recovery
    Home, home health, outpatient therapy, skilled nursing, and inpatient rehabilitation offer different intensity, nursing, medical oversight, equipment, and caregiver demands. The nearest open bed is not a clinical outcome.
  29. Falls After Hospital Discharge: Reassess the New Risk State
    A recent admission can change strength, balance, blood pressure, cognition, medicines, vision, footwear, devices, and the home routine. A person who was safe before hospitalization may leave with a different falls profile.
  30. Medication-Related Falls: Review Mechanisms Without Stopping Everything
    Medicines can contribute to falls through sedation, slowed reaction, orthostatic pressure, bradycardia, hypoglycemia, bleeding consequences, vision change, urgency, or interactions. The fall may also reveal disease or environmental risk.
  31. Inflammatory Arthritis: Morning Stiffness Is a Pattern, Not a Diagnosis
    Persistent joint swelling, warmth, prolonged stiffness, tendon insertion pain, dactylitis, rash, eye inflammation, or systemic features should trigger a cause-focused evaluation before damage accumulates.
  32. Polymyalgia Rheumatica: Rapid Steroid Response Helps, but Does Not Prove the Diagnosis
    New bilateral shoulder or hip-girdle pain and prolonged stiffness after 50 can be PMR, but infection, cancer, endocrine disease, medication injury, arthritis, myopathy, and giant cell arteritis must be considered.
  33. Psoriatic Arthritis: Treat Joints, Entheses, Spine, Skin, and Cardiometabolic Risk Together
    Psoriatic arthritis can involve peripheral joints, tendon insertions, whole digits, spine, skin, nails, eyes, and bowel; the dominant domain should guide therapy.

Open the focused topic page →

Eat for the long run

Nutrition & Metabolic Health

Dietary patterns, protein, fiber, food processing, and metabolic risk without superfood theater.

28 evidence articles

  1. Dietary Patterns Matter More Than Superfoods
    No single food can carry the work of an overall diet, and no ingredient makes a diet immortal.
  2. Fiber Is a Food Pattern, Not Just a Number
    Fiber-rich foods bring structure, nutrients, and food context that a supplement total does not fully capture.
  3. Carbohydrate Quality Is More Useful Than Carb Fear
    The source and structure of carbohydrate often matter more than treating an entire nutrient class as good or bad.
  4. Sodium: The Big Picture Beyond the Salt Shaker
    For many people, packaged and restaurant foods contribute more sodium than salt added at the table.
  5. Dietary Fat: Think Replacement, Not Removal
    Lowering one kind of fat only helps if the replacement supports health.
  6. Protein in Later Life: Food, Training, and Context
    Protein supports muscle, but resistance exercise is the signal that nutrition alone cannot replace.
  7. Protein Timing: Interesting, Not Magical
    Distribution may matter at the margins, but total intake, training, and meal quality remain the bigger questions.
  8. What the Ultra-Processed Food Trial Did—and Did Not—Show
    A tightly controlled study found higher intake and weight gain, but it did not identify one guilty ingredient.
  9. Mediterranean-Style Eating: Strong Idea, Messy Evidence
    A plant-rich pattern is sensible, while the size and certainty of specific clinical benefits vary by trial and outcome.
  10. Supplements Are Tools, Not a Longevity Foundation
    A supplement can correct a gap or serve a clinical purpose; it does not inherit every association seen with nutrient-rich foods.
  11. Calorie Restriction in Humans: What CALERIE Proved—and What It Did Not
    The strongest long-term randomized human study improved several risk markers and one pace-of-aging measure, but it did not test whether people live longer.
  12. Time-Restricted Eating: A Schedule, Not a Longevity Shortcut
    Shorter eating windows can help some metabolic markers, but calorie intake, timing, adherence, and the comparison diet shape the result.
  13. Creatine in Older Adults: Useful Adjunct, Not a Longevity Drug
    Creatine monohydrate can modestly augment some resistance-training gains. Evidence for cognition and long-term clinical outcomes is much less certain.
  14. Diabetes Deintensification in Older Adults: Safer Targets Are Still Active Care
    When hypoglycemia risk, frailty, cognitive change, or treatment burden rises, simplifying insulin or sulfonylureas can be safer than defending a historical A1C target.
  15. Vitamin D and Calcium for Fracture Prevention: Test the Claim Against the Population
    A supplement can correct a deficiency without automatically preventing fractures in every community-dwelling adult. Baseline status, osteoporosis, diet, falls, dose, and outcome all change the answer.
  16. Subclinical Hypothyroidism After 65: A Mild TSH Rise Is Not Automatically a Treatment Target
    Subclinical hypothyroidism means an elevated thyroid-stimulating hormone with free thyroxine still in range. In older adults with mostly mild persistent elevations, lowering TSH did not improve symptoms in a large trial.
  17. Dentures, Chewing, and Nutrition: Fit and Function Matter More Than Tooth Counts Alone
    Replacing missing teeth can improve appearance and chewing options, but dentures do not automatically restore natural bite force, dietary quality, or nutritional status. Fit, pain, saliva, skill, food access, and adaptation matter.
  18. Constipation in Older Adults: Find the Cause Before Building a Laxative Stack
    Constipation can mean infrequent stools, hard stool, straining, incomplete emptying, or blockage. Medicines, hydration, diet, mobility, pelvic floor function, neurologic disease, and obstruction require different responses.
  19. Fatty Liver Disease: Stage Fibrosis, Not Just Fat
    Metabolic dysfunction-associated steatotic liver disease ranges from fat without advanced injury to inflammatory MASH, fibrosis, cirrhosis, and cancer risk. Fibrosis—not a wellness ultrasound score—drives prognosis and referral.
  20. Vitamin B12 Deficiency: Treat the Nerves and Blood, Not Just a Borderline Number
    B12 deficiency can affect blood, peripheral nerves, spinal cord, cognition, tongue, and energy. Neurologic injury can occur without dramatic anemia, while a borderline serum value needs context.
  21. Gout: Lower Urate Deliberately Instead of Chasing Purine Perfection
    Gout is crystal arthritis driven by sustained urate supersaturation. Flares are episodic, but the crystal burden persists between them and can be reduced with monitored long-term therapy.
  22. Cancer Cachexia: Nutrition Matters, but Food Alone Cannot Reverse the Syndrome
    Cancer cachexia is a multifactorial wasting syndrome involving ongoing muscle loss, altered metabolism, inflammation, reduced intake, weakness, and functional decline, especially in advanced disease.
  23. Supplements During Cancer Treatment: Natural Products Can Change Drug Exposure
    Herbs, concentrated extracts, vitamins, minerals, teas, and special diets can alter drug metabolism, transport, bleeding, liver injury, sedation, immunity, or treatment adherence. Labels rarely establish oncology safety.
  24. Malnutrition in the Hospital: Screen Early, Diagnose the Cause, Protect Muscle
    Weight loss and low intake can hide behind obesity, edema, intravenous fluid, or a normal albumin. During illness, malnutrition and inactivity accelerate weakness, impaired healing, and loss of independence.
  25. Severe Hypoglycemia: Treat First, Then Redesign the Regimen
    Hypoglycemia can cause sweating, tremor, hunger, palpitations, behavior change, confusion, seizure, or unconsciousness. Older adults may have fewer warning symptoms, and beta blockers or repeated episodes can alter awareness.
  26. Hyperglycemic Crises: DKA and HHS Need Immediate Medical Care
    Diabetic ketoacidosis and hyperosmolar hyperglycemic state are life-threatening metabolic emergencies involving insulin deficiency, dehydration, electrolyte shifts, and precipitating illness. They can overlap.
  27. Eating and Swallowing in Dementia: Separate Appetite, Access, and Safety
    Weight loss or prolonged meals can arise from environment, oral disease, depression, medicines, motor problems, or dysphagia; each requires a different response.
  28. Nutrition and Wound Healing: Correct Deficiency Without Selling a Miracle Formula
    Energy, protein, micronutrients, hydration, perfusion, pressure relief, infection control, and disease burden interact; no supplement can compensate for untreated ischemia or repeated tissue loading.

Open the focused topic page →

Protect recovery

Sleep & Recovery

Sleep duration, regularity, insomnia, breathing disorders, and realistic recovery practices.

12 evidence articles

  1. How Much Sleep Do Adults Need?
    Seven or more hours is a useful population anchor, while individual need and sleep quality still vary.
  2. Sleep Regularity: Why Timing Deserves Attention
    The body clock responds to repeated timing cues, especially light and daily schedules.
  3. A Bad Night Is Not the Same as Insomnia
    Insomnia involves persistent difficulty and daytime impact despite adequate opportunity—not occasional imperfect sleep.
  4. CBT-I: More Than Sleep Hygiene
    Cognitive behavioral therapy for insomnia is a structured treatment, not a list of bedroom tips.
  5. Sleep Apnea Is Not Just Loud Snoring
    Breathing pauses, gasping, morning headaches, and daytime sleepiness can signal a treatable disorder.
  6. Alcohol May Shorten the Path to Sleep—and Worsen the Night
    Sedation is not the same as restorative sleep.
  7. Naps: Useful Tool, Imperfect Signal
    A short nap can restore alertness, while frequent long naps may reflect inadequate or disrupted nighttime sleep.
  8. Light, the Body Clock, and Better-Timed Sleep
    Light is a powerful timing cue; when it arrives can matter as much as how bright it is.
  9. What a Sleep Tracker Can—and Cannot—Tell You
    Consumer devices estimate patterns; they do not measure sleep the way a clinical study does.
  10. When Sleep Problems Need More Than Better Habits
    Persistent insomnia, breathing symptoms, dangerous sleepiness, or unusual movements deserve evaluation.
  11. Obstructive Sleep Apnea: Screen Selectively, Evaluate Symptoms Seriously
    Evidence is insufficient for universal screening of adults without recognized symptoms, while loud snoring, witnessed pauses, sleepiness, resistant hypertension, or nocturnal choking can justify a structured diagnostic pathway.
  12. Over-the-Counter Sleep Aids: The Hidden Antihistamine Is Still a Drug
    Many nighttime and combination cold or pain products contain sedating first-generation antihistamines. Familiar packaging and nonprescription status do not remove anticholinergic, next-day, falls, urinary, and interaction risks.

Open the focused topic page →

Stay connected

Brain & Mental Wellbeing

Cognition, mood, hearing, stress, purpose, and social connection across later life.

46 evidence articles

  1. Brain Health Has No Single Master Switch
    Cognition reflects vascular health, hearing, sleep, mood, education, activity, social life, and disease—not one supplement.
  2. Dementia Risk Is Modifiable—but Not Fully Controllable
    Some risk can be shifted across the life course; genes, disease, age, and chance still matter.
  3. Exercise and Cognition: Encouraging, Not Magical
    Movement supports overall and brain health, while trial results vary by activity, population, and cognitive outcome.
  4. Hearing Is a Brain-Health Issue and a Communication Issue
    Hearing loss can change connection, safety, effort, and cognitive testing; it is not merely an inconvenience.
  5. Loneliness and Social Isolation Are Not the Same
    One describes felt disconnection; the other describes limited contact. Their solutions can differ.
  6. Depression Is Not a Normal Part of Aging
    Later life can bring loss and change, but persistent depression is a health condition worthy of care.
  7. Mindfulness: A Skill With Modest, Uneven Evidence
    Mindfulness can be useful practice, but it is not a cure-all or a substitute for mental-health treatment.
  8. Purpose and Creative Activity: Meaning Before Metrics
    Meaningful activity can enrich later life even when a biomarker effect is unknown.
  9. Stress Recovery Is a System, Not a Single Hack
    Stress response is shaped by sleep, movement, relationships, health, environment, and coping resources.
  10. Memory Change: Notice the Pattern, Not One Forgotten Name
    Occasional lapses happen; persistent change that disrupts daily life deserves assessment.
  11. Hearing Intervention After ACHIEVE: Communication Benefits Are the Certain Part
    The landmark ACHIEVE trial improved communication and produced intriguing subgroup and secondary findings, but its primary cognitive result was neutral in the full cohort.
  12. Alzheimer's Blood Tests: Diagnostic Aid, Not a Wellness Screen
    The first FDA-cleared blood test can help evaluate cognitively impaired adults in specialized care, but it is not cleared for population screening or as a stand-alone diagnosis.
  13. Lecanemab and Donanemab: Slower Early Alzheimer's Decline With Serious Tradeoffs
    Anti-amyloid antibodies modestly slow decline in selected people with early symptomatic Alzheimer's disease; they do not restore lost cognition or prevent disease in healthy adults.
  14. Delirium in the Hospital: Prevention Is Multicomponent and Confusion Is Urgent
    Acute fluctuating confusion is not ordinary aging or automatically dementia; it often signals illness, medication effects, surgery, pain, or a hazardous care environment.
  15. Late-Life Depression: Screening Works Only When Care Follows
    A brief questionnaire can open the door, but benefit depends on confirmation, suicide-safety assessment, treatment choice, follow-up, and adjustment inside a functioning care system.
  16. Suicide Prevention in Later Life: Warning Signs Require Action
    Population screening evidence is uncertain, but new suicidal thoughts, preparations, hopelessness, agitation, withdrawal, or a major behavioral change are actionable clinical signals—not a reason to wait for a questionnaire.
  17. Loneliness in Later Life: Match the Intervention to the Cause
    Loneliness is the painful feeling that relationships are insufficient; social isolation is an objective shortage of contact. They overlap, but different causes call for different solutions.
  18. Dementia Caregiving: Navigation and Support Help, but Effects Vary
    Caregiver education, navigation, respite, safety planning, and coordinated medical and community support can improve parts of the experience, but no single program reliably solves every family's needs.
  19. Sudden Hearing Loss Is an Emergency: Do Not Wait for Earwax to Clear
    A rapid drop in hearing over hours or days can be mistaken for congestion or wax. Sudden sensorineural hearing loss is time-sensitive because earlier diagnosis and treatment may preserve more hearing.
  20. Earwax Impaction: Treat Symptoms and Blocked Examinations, Not Every Speck of Wax
    Cerumen protects the ear canal. It becomes an impaction when it causes symptoms or prevents needed examination, and removal method must account for the eardrum, surgery history, anticoagulation, diabetes, immune status, and anatomy.
  21. Tinnitus: Reduce Distress, Restore Hearing, and Investigate the Red Flags
    Tinnitus is a sound perceived without an external source. There is no universal cure, but hearing care, cognitive behavioral therapy, sound strategies, sleep care, and treatment of defined causes can reduce its impact.
  22. Cochlear Implants in Older Adults: Refer When Well-Fit Hearing Aids Are Not Enough
    Age alone should not close the door to cochlear-implant evaluation. Candidacy depends on sensorineural loss and limited aided speech understanding, while outcomes require surgery, programming, rehabilitation, and realistic expectations.
  23. Peripheral Neuropathy: Name the Pattern Before Treating the Tingling
    Peripheral neuropathy describes damage to sensory, motor, or autonomic nerves, not one disease. Distribution, tempo, weakness, exposures, and systemic clues determine which causes and tests matter.
  24. A First Seizure in Later Life: Find the Trigger Before Naming Epilepsy
    A seizure may be provoked by an acute metabolic, toxic, infectious, or structural problem, or it may be unprovoked. That distinction shapes recurrence risk and long-term treatment.
  25. Chemotherapy-Induced Peripheral Neuropathy: Prevention Claims Are Ahead of Evidence
    Some chemotherapy injures peripheral nerves, causing numbness, tingling, pain, weakness, balance loss, or fine-motor difficulty. The best-supported strategy remains early recognition and treatment-dose decision-making.
  26. Cancer-Related Cognitive Change: Validate the Symptom, Broaden the Differential
    Attention, memory, processing speed, and executive-function changes can occur before, during, or after cancer treatment. 'Chemo brain' is real shorthand but an incomplete diagnosis.
  27. Preventing Postoperative Delirium: Make Brain Safety Everyone's Job
    Postoperative delirium is an acute, fluctuating disturbance of attention and cognition. It is common in vulnerable patients, often missed when quiet, and associated with complications, longer care, functional loss, and distress.
  28. Cognitive Change After Surgery: Use the Right Name and the Right Timeline
    Confusion in the recovery room, delirium over several days, and persistent memory or executive problems weeks later are not one condition. Clear timing and objective change prevent both dismissal and overdiagnosis.
  29. Anticholinergic Burden: Review the Whole Regimen, Not One Score
    Medicines with anticholinergic effects can add dry mouth, constipation, urinary retention, blurred vision, sedation, confusion, and falls risk. Burden scores disagree and do not prove that a drug caused dementia or an individual symptom.
  30. Benzodiazepine Tapering: Slow Enough to Be Safe, Flexible Enough to Work
    Benzodiazepines can relieve defined symptoms but cause dependence, sedation, impaired balance, cognitive effects, and dangerous interactions. Physical dependence is expected with regular use and is not the same as a substance use disorder.
  31. After a Dementia Diagnosis: Build the Care System Before the Crisis
    The first months are for confirming the clinical picture, preserving the person's voice, closing safety gaps, and assigning work—not trying to predict every future stage.
  32. Decision-Making Capacity in Dementia Is Specific, Supported, and Reassessed
    A diagnosis does not answer whether someone can make a particular decision today, and difficulty should trigger support before substitution.
  33. Living Alone With Early Dementia: Test the System, Not Just the Memory
    Living alone is not automatically unsafe, but it becomes sustainable only when essential tasks, backup capacity, and change detection are explicit.
  34. Driving With Dementia: Plan the Transition Before a Crash
    Some people drive safely early in a dementia course, but progressive cognitive disease requires observation, reassessment, local-law review, and a transportation alternative.
  35. Wandering and Getting Lost in Dementia: A Layered Safety Plan
    Wandering is not solved by one lock or tracker; prevention, rapid recognition, identification, response, and attention to unmet needs must work together.
  36. Dementia Home Safety Without Turning Home Into a Prison
    Good safety design reduces predictable failure while preserving recognition, movement, dignity, and as much self-direction as possible.
  37. Agitation in Dementia: Look for a Cause Before Reaching for a Sedative
    Agitation is a description, not an explanation; pain, delirium, fear, environment, communication, and medication effects can all look similar.
  38. Hallucinations and Delusions in Dementia: Safety, Distress, and Diagnosis First
    Arguing about reality often increases distress; the first clinical questions are whether the experience is new, dangerous, medically triggered, and part of a specific dementia syndrome.
  39. Bathing, Dressing, and Grooming in Dementia: Design for Dignity
    Personal care succeeds when the task, environment, timing, privacy, pain, and communication fit the person—not when compliance is forced.
  40. Medication Management in Dementia: Make the System Observable
    A pillbox is useful only when selection, filling, administration, monitoring, refills, and error response each have an accountable owner.
  41. Hospital Care With Dementia: Prevent Delirium and Preserve Baseline
    The hospital needs to know who the person was before illness; otherwise delirium, pain, functional loss, and communication failure can be mistaken for chronic dementia.
  42. Dementia Caregiver Health: Support Is Part of the Treatment Plan
    A care plan that depends on one exhausted person without backup is clinically fragile, even when the caregiver is devoted and capable.
  43. Choosing a Nursing Home for Dementia Care: Ratings Are a Starting Point
    Public ratings help screen facilities, but they cannot show whether staffing, communication, clinical capability, and daily life fit one person's needs.
  44. Moving a Person With Dementia: Reduce Transfer Shock and Information Loss
    A move changes cues, people, routines, medicines, and responsibility at once; careful transfer of identity and clinical information can reduce avoidable distress.
  45. Care Conferences in Dementia: Turn Updates Into Decisions
    A useful care conference compares current function with baseline, names uncertainties, assigns work, and records what outcome will trigger the next choice.
  46. Fatigue in Autoimmune Disease: Measure Inflammation, Sleep, Blood, Mood, and Function
    Fatigue may persist even when inflammatory markers improve; active disease, anemia, sleep apnea, pain, depression, medicines, endocrine disease, infection, deconditioning, and caregiving can coexist.

Open the focused topic page →

Use care wisely

Prevention & Care

Screening, risk conversations, vaccination, tobacco, alcohol, and shared decisions.

125 evidence articles

  1. Blood Pressure Screening Works Only if the Measurement Is Real
    A single clinic reading can start a question; it should not always end it.
  2. Home Blood Pressure: Technique Before Interpretation
    Measurement error can be larger than the change a person is trying to track.
  3. Cholesterol Is a Risk Conversation, Not a Good-vs-Bad Scorecard
    Lipid values matter within a history of exposure, disease, age, blood pressure, diabetes, smoking, and family risk.
  4. Prediabetes Screening: Who the Recommendation Covers
    Screening guidance is written for a defined population, not every reader in every circumstance.
  5. The Diabetes Prevention Program Is More Than Advice
    The evidence-based model combines coaching, curriculum, activity, eating changes, problem-solving, and sustained support.
  6. Tobacco Cessation: Proven Help Beats Willpower Myths
    Behavioral support and approved medicines can improve quit success; needing help is not failure.
  7. Alcohol and Cancer: The Risk Starts Below ‘Heavy Drinking’
    Alcohol causally increases the risk of at least seven cancers, and risk generally rises with greater consumption.
  8. Adult Vaccination Is a Living Schedule
    Age, prior doses, health conditions, risk, season, and changing recommendations all shape the plan.
  9. Colorectal Cancer Screening: Several Good Paths
    Stool-based and visualization tests differ in frequency, preparation, follow-up, and what they detect.
  10. Cancer Screening Has Benefits, Harms, and Boundaries
    A screening test can prevent death while also producing false positives, procedures, anxiety, and overdiagnosis.
  11. Daily Aspirin Is Not a General Longevity Strategy
    For preventing a first heart attack or stroke, cardiovascular benefit must be weighed against bleeding—and initiating aspirin at age 60 or older has no net benefit on average.
  12. Osteoporosis Screening Is Fracture Prevention, Not a Score-Chasing Exercise
    The 2025 USPSTF recommendation supports screening women 65 and older and younger postmenopausal women at increased risk, while evidence remains insufficient for routine screening in men.
  13. Menopausal Hormone Therapy: Symptom Treatment Is Not a Longevity Prescription
    Hormone therapy can be highly effective for selected menopausal symptoms, but formulation, timing, health history, and treatment goal determine its benefit-risk balance.
  14. Testosterone in Older Men: Treat Diagnosed Hypogonadism, Not Aging Itself
    TRAVERSE answered an important cardiovascular safety question in men with symptoms and repeatedly low testosterone; it did not validate testosterone as a general vitality or longevity treatment.
  15. Starting a Statin After 75: High Risk, Real Uncertainty, Better Questions
    Older adults have high cardiovascular risk, yet direct randomized evidence for starting statins after age 75 without known cardiovascular disease remains thinner than many summaries imply.
  16. Cataract Care: Restore Vision First, Treat Longevity Claims as Secondary
    Cataract surgery reliably improves vision for most appropriate patients; broader claims about falls, cognition, and survival range from trial-supported in narrow groups to observational and uncertain.
  17. Deprescribing: Safer Medication Use Is Not a Contest to Take Fewer Pills
    Structured medication review can remove drugs that no longer fit a person's goals or risks, but indiscriminate stopping can trade one harm for another.
  18. RSV Vaccination in Later Life: Who Is Recommended to Receive It Now
    Current U.S. guidance uses age and severe-disease risk, not annual revaccination or a universal recommendation for every adult over 60.
  19. Pneumococcal Vaccination After 50: The Current U.S. Schedule in Plain Language
    The adult starting age is now 50, while the correct next dose depends on which pneumococcal vaccines a person has already received.
  20. High-Dose Influenza Vaccine After 65: Better Protection, Bounded Claims
    Enhanced influenza vaccines are preferred for adults 65 and older when available, but vaccination should not be delayed if only another age-appropriate product is on hand.
  21. Blood Pressure Targets After 75: What SPRINT Shows and What It Does Not
    Intensive systolic pressure control reduced cardiovascular events and mortality in selected ambulatory older adults, but the trial population and measurement method define the result.
  22. Orthostatic Hypotension: Measure the Standing Pressure Before Blaming Age
    Dizziness or weakness on standing can reflect medications, dehydration, autonomic disease, illness, anemia, or cardiovascular problems and deserves a structured evaluation.
  23. Anticoagulation, Atrial Fibrillation, and Falls: Replace the Reflex With Risk Balance
    Fall history matters, but automatically withholding stroke prevention can expose an older adult to a devastating and preventable embolic stroke.
  24. Finding Chronic Kidney Disease: Why eGFR and Urine Albumin Belong Together
    A creatinine result alone can miss important kidney risk; filtration and kidney-damage markers answer different parts of the question.
  25. Lung Cancer Screening: Low-Dose CT Helps the Right High-Risk Population
    Annual low-dose CT reduces lung-cancer mortality in people with a substantial smoking history, but chest x-rays and scanning low-risk people do not inherit that benefit.
  26. Colorectal Cancer Screening: The Best Test Is the Program You Complete
    Stool tests and direct-visualization tests can support effective screening, but every non-colonoscopy option depends on completing colonoscopy after an abnormal result.
  27. Dense Breasts After Mammography: Information, Not an Automatic MRI Order
    Breast density both masks cancers on mammography and raises risk, but supplemental ultrasound or MRI has not yet shown a clear net benefit for every person with dense tissue.
  28. PSA Screening: A Small Long-Term Mortality Benefit With Real Overdiagnosis
    Longer European trial follow-up strengthens evidence that repeated PSA screening can reduce prostate-cancer deaths, while the absolute benefit remains modest and excess diagnosis persists.
  29. Routine Skin-Cancer Screening: Evidence Is Insufficient, but Changing Lesions Matter
    A population-wide clinician skin exam has not been shown to reduce mortality, while a new or changing lesion is a symptom and deserves evaluation.
  30. Radon at Home: Test the Building, Then Fix Elevated Levels
    Radon is invisible and odorless, varies from one building to another, and is a preventable cause of lung cancer; measurement is the only way to know a home's level.
  31. COPD Screening: Do Not Test Everyone, but Do Investigate Symptoms
    The evidence argues against screening adults who do not report respiratory symptoms, not against spirometry when persistent breathlessness, cough, sputum, or wheeze needs an explanation.
  32. Palliative Care and Hospice: Related Services, Different Eligibility
    Palliative care can accompany treatment at any stage of serious illness; hospice is a specific end-of-life model with eligibility and coverage rules. Both focus on comfort, goals, and support.
  33. Hospital at Home: Real Acute Care for Carefully Selected Patients
    Hospital-at-home programs can deliver inpatient-level treatment in a residence and may reduce cost, length of stay, or readmission for selected patients, but capacity and eligibility are not interchangeable across programs.
  34. COVID-19 Vaccination After 65: Use the Current Season, Not an Old Dose Count
    Current COVID-19 vaccination is designed to add protection against severe disease as immunity and circulating variants change; the applicable product and schedule depend on age, immune status, and prior doses.
  35. Long COVID: A Clinical Diagnosis Without One Definitive Test
    Long COVID can affect one or more organ systems and fluctuate over time; normal routine tests do not invalidate symptoms, while alternative and urgent diagnoses still require active evaluation.
  36. Long COVID Treatment Claims: Pacing, Rehabilitation, and Mixed Metformin Trials
    No single approved treatment resolves the full syndrome. Rehabilitation must match the phenotype, and two metformin trials provide encouraging but not identical prevention results.
  37. Sepsis in Older Adults: Dangerous Change Can Arrive Without a Textbook Fever
    Sepsis is life-threatening organ dysfunction caused by a dysregulated response to infection. Confusion, breathing difficulty, clammy skin, extreme pain, or a weak pulse can be urgent even when fever is absent.
  38. A Positive Urine Culture Is Not Automatically a UTI
    Bacteria and white cells are common in urine from older adults without urinary infection symptoms. Treating that finding usually adds drug harm and resistance without clinical benefit.
  39. Antibiotic Stewardship: The Right Drug, Dose, Route, and Duration
    Antibiotics save lives when bacterial infection is likely or dangerous; unnecessary or excessively broad treatment creates immediate patient harm and preserves selective pressure for future resistance.
  40. NSAIDs in Later Life: Topical and Oral Risk Are Not Interchangeable
    NSAIDs can relieve inflammatory and musculoskeletal pain, but oral exposure can raise bleeding, kidney, blood-pressure, heart-failure, heart-attack, and stroke risk—especially with age and comorbidity.
  41. Long-Term Opioids: Safer Prescribing Does Not Mean Forced Rapid Tapering
    Opioids can reduce pain for some people and can also cause sedation, falls, constipation, dependence, overdose, and respiratory depression. Starting, continuing, and tapering are separate decisions.
  42. Neuropathic Pain: Modest Average Drug Benefits, Important Safety Differences
    Burning, electric, shooting, numb, or touch-evoked pain can reflect a lesion or disease of the somatosensory system. Diagnosis comes before choosing a so-called nerve-pain drug.
  43. AREDS2 Supplements: Useful for Specific AMD Stages, Not General Eye Prevention
    The AREDS2 formula slows progression for people with intermediate age-related macular degeneration or late disease in one eye; it does not prevent AMD onset or treat every vision problem.
  44. Glaucoma: Screening Evidence Is Uncertain, but Diagnosed Disease Is Treatable
    The USPSTF finds insufficient evidence that population screening improves outcomes, while randomized treatment trials show that lowering eye pressure slows progression in many people with diagnosed open-angle glaucoma.
  45. Low-Vision Rehabilitation: Protect Independence Even When Vision Cannot Be Restored
    Low vision remains after ordinary glasses, medicine, or surgery; rehabilitation redesigns tasks, tools, environments, and support so a person can keep doing what matters.
  46. Bisphosphonate Drug Holidays: Reassess Risk, Do Not Stop by Calendar Alone
    Bisphosphonates persist in bone after treatment, allowing some lower-risk patients a monitored pause. A holiday is a risk-management strategy, not a cure or an automatic anniversary event.
  47. Stopping Denosumab: Prevent the Rebound Before the Next Dose Is Missed
    Denosumab does not remain stored in bone like a bisphosphonate. Delayed or stopped treatment can unleash rapid bone turnover and multiple vertebral fractures unless another antiresorptive strategy is arranged.
  48. After a Fragility Fracture: Use a Fracture Liaison Service to Close the Treatment Gap
    A low-trauma fracture is a sentinel event, yet bone evaluation and treatment are often lost between emergency, surgical, rehabilitation, and primary care. A fracture liaison service assigns the gap to a system.
  49. Dry Mouth Is Not Normal Aging: Protect Saliva, Teeth, Nutrition, and Speech
    Saliva protects teeth, tissue, taste, swallowing, and speech. Persistent dryness is commonly medication- or disease-related and can accelerate cavities, infection, poor intake, and social withdrawal.
  50. Periodontal Treatment and Heart Health: Treat the Gums Without Promising Fewer Heart Attacks
    Gum disease and cardiovascular disease share risk factors and inflammatory pathways. Treating periodontitis improves oral outcomes, while small changes in blood pressure or biomarkers do not prove prevention of myocardial infarction or stroke.
  51. Oral Cancer: Persistent Symptoms Need Examination Even When Screening Evidence Is Uncertain
    An insufficient-evidence population screening recommendation is not advice to ignore a persistent mouth or throat change. Symptoms, risk, dental examination, and population screening are different clinical questions.
  52. Genitourinary Syndrome of Menopause: Local Symptoms, Local Options, Individual Risk
    Low estrogen can affect vulvar and vaginal tissue, lubrication, comfort, urinary symptoms, and sexual function. The syndrome is common, treatable, and often missed because patients assume it is inevitable or too private to discuss.
  53. Recurrent Urinary Tract Infection After Menopause: Confirm Recurrence Before Adding Prevention
    Repeated urinary symptoms can reflect bacterial infection, genitourinary syndrome, urgency, retention, stones, or another cause. Prevention evidence is strongest when episodes and the target population are clearly defined.
  54. BPH and Lower Urinary Tract Symptoms: Balance Relief Against Retention, Pressure, and Falls
    Slow stream, hesitancy, urgency, frequency, and nighttime urination are often attributed to an enlarged prostate, but bladder, neurologic, medicine, sleep, infection, and fluid factors can produce the same symptoms.
  55. Erectile Dysfunction Can Be a Vascular Signal: Evaluate Risk Before Reaching for a Pill
    Persistent erectile dysfunction can reflect vascular, neurologic, hormonal, medication, psychological, or relationship factors. It can precede recognized cardiovascular disease and should open a respectful health assessment.
  56. Acute Kidney Injury During Illness: Build a Sick-Day Plan Before Dehydration
    Vomiting, diarrhea, fever, poor intake, infection, heat, and low blood pressure can reduce kidney perfusion. Several helpful long-term medicines may need temporary review, but generic hold lists can also cause harm.
  57. Hepatitis C: One Test Can Find a Curable Chronic Infection
    Hepatitis C can remain silent for years while causing fibrosis, cirrhosis, liver cancer, and extrahepatic disease. Antibody screening followed automatically by RNA confirmation connects detection to curative oral therapy.
  58. Hepatitis B After 60: Screening and Vaccination Answer Different Questions
    Vaccination prevents future infection; a triple-panel blood test identifies current infection, past exposure, or vaccine immunity. Receiving a vaccine does not diagnose or treat chronic hepatitis B.
  59. Long-Term Proton Pump Inhibitors: Keep a Valid Indication, Deprescribe a Habit
    PPIs are highly effective for acid-related disease and bleeding prevention in the right patient. The safety problem is indefinite use without a current indication—and the opposite error is stopping necessary therapy because of observational headlines.
  60. Dysphagia in Older Adults: Swallowing Safety Is More Than Thickening Every Drink
    Coughing, a wet voice, food sticking, long meals, weight loss, recurrent pneumonia, or inability to swallow pills can signal oral, throat, esophageal, neurologic, structural, or medication problems.
  61. Uncomplicated Diverticulitis: Antibiotics Are Selective, Not Automatic
    Inflamed diverticula can range from stable uncomplicated disease to abscess, perforation, obstruction, peritonitis, or sepsis. Evidence supporting observation without antibiotics applies to carefully selected stable patients, not the entire spectrum.
  62. Helicobacter pylori: Treat the Infection, Confirm Eradication, Reduce Gastric Cancer Risk
    H. pylori is a bacterial cause of peptic ulcer and gastric cancer. Antibiotic resistance makes regimen choice important, and symptom improvement does not prove the organism is gone.
  63. Sun Protection After Decades of Exposure: Prevention Still Matters
    Past ultraviolet exposure cannot be erased, but additional cumulative damage can be reduced. Clothing, shade, timing, hats, sunglasses, and correctly applied broad-spectrum sunscreen work as a layered system.
  64. Actinic Keratosis: Treat the Sun-Damaged Field Without Calling Every Spot Cancer
    Actinic keratoses are rough sun-damaged lesions with potential to progress to squamous-cell cancer, but individual lesion fate is uncertain. A field can contain visible and subclinical damage.
  65. Pressure Injuries: Prevention Is a Reliable Care System, Not a Turning Slogan
    Pressure and shear damage skin and deeper tissue, often over bone or under a device. Immobility, poor perfusion, moisture, nutrition, sensation, illness, and equipment determine risk, and no single schedule prevents every injury.
  66. Parkinson's in the Hospital: Medication Timing and Dopamine Blockers Are Safety Issues
    A hospitalization for infection, surgery, or injury can destabilize Parkinson symptoms when a personalized regimen is converted to routine medication times or dopamine-blocking drugs are added.
  67. Stroke Warning Signs in 2026: Call Emergency Services, Even if Symptoms Improve
    Sudden balance, vision, face, arm, or speech change is a time-sensitive emergency. Modern reperfusion windows are more individualized, which makes rapid transport and imaging more—not less—important.
  68. Transient Ischemic Attack: Temporary Symptoms Need Permanent Prevention
    A TIA is not reassuring because the weakness or speech change went away. Early stroke risk is concentrated in the first hours and days, when rapid cause-specific prevention can matter most.
  69. New Headache After 50: Giant Cell Arteritis Can Threaten Sight
    New headache, scalp tenderness, jaw fatigue with chewing, visual symptoms, or polymyalgia symptoms after age 50 can signal giant cell arteritis, an inflammatory vascular disease requiring urgent evaluation.
  70. Iron Deficiency After Menopause or in Men: Replace Iron and Find the Loss
    Iron deficiency can reflect gastrointestinal blood loss, malignancy, ulcer disease, celiac disease, malabsorption, surgery, diet, or repeated donation. Replacing iron is only half of the work.
  71. Rheumatoid Arthritis in Later Life: Control Inflammation Without Losing Safety
    Rheumatoid arthritis can destroy joints, reduce function, and add systemic risk. Older adults deserve disease control, with deliberate attention to infection, kidney and liver function, vaccines, bone, cardiovascular risk, and treatment burden.
  72. A Cancer Survivorship Plan: Keep the Treatment History and the Next Decisions Together
    Cancer follow-up must coordinate recurrence surveillance, second-cancer prevention, treatment late effects, chronic disease, function, mental health, medicines, and clear ownership across oncology and primary care.
  73. Cancer Therapy and the Heart: Match Surveillance to Exposure and Baseline Risk
    Anthracyclines, HER2 therapy, chest radiation, immune checkpoint inhibitors, some targeted therapies, and hormonal treatments can affect heart muscle, vessels, rhythm, valves, pericardium, pressure, or thrombosis.
  74. Bone Health After Cancer: Treatment Exposure Changes Fracture Risk
    Aromatase inhibitors, androgen-deprivation therapy, premature menopause, steroids, chemotherapy, transplant, reduced activity, nutrition problems, and some radiation fields can accelerate bone loss.
  75. Immune Checkpoint Toxicity: New Inflammation Can Affect Almost Any Organ
    Checkpoint inhibitors activate antitumor immunity but can trigger inflammatory injury in skin, bowel, liver, endocrine glands, lungs, heart, nerves, muscles, kidneys, blood, eyes, joints, and other organs.
  76. Cancer-Associated Blood Clots: Prevention and Treatment Depend on Bleeding Risk
    Cancer, surgery, hospitalization, immobility, central venous catheters, and some systemic therapies increase venous thromboembolism risk, while tumors, low platelets, procedures, and medicines can also increase bleeding.
  77. Surgery Goals and Advance Planning: Decide Before the Crisis Chooses
    Consent describes an operation; high-quality decision-making also describes the likely life afterward, acceptable rescue treatments, a surrogate, and what to do if complications make the original goal unreachable.
  78. Enhanced Recovery After Surgery: A Coordinated Pathway, Not a Race Home
    Enhanced recovery pathways coordinate evidence-based steps before, during, and after surgery to reduce physiologic stress and restore function. Early discharge is an outcome only when readiness and follow-up are real.
  79. Medication Reconciliation at Discharge: Rebuild One Authoritative List
    Hospital treatment starts, stops, holds, substitutes, and changes medicines. Without deliberate reconciliation, temporary orders, duplicate products, old doses, and omitted chronic therapy can cross into home.
  80. A High-Quality Medication Review: Give Every Drug a Job, Target, and Exit
    Counting medicines can reveal complexity but cannot tell whether a regimen is appropriate. A useful review links each product to a current purpose, expected benefit, measurable target, monitoring, burden, and stopping rule.
  81. Stacked Sedatives: Opioids, Benzodiazepines, Gabapentinoids, and Alcohol Add Risk
    Several medicines may each be reasonable for a defined condition yet become dangerous together. Sedation, slowed breathing, impaired balance, confusion, and driving risk can accumulate across prescriptions, over-the-counter products, alcohol, and cannabis.
  82. Prescribing Cascades: Ask Whether the New Diagnosis Is a Drug Effect
    A prescribing cascade begins when an adverse drug effect is mistaken for a new disease and another medicine is added. The second drug can create its own harms while the first exposure continues.
  83. Over-the-Counter NSAIDs: Short Access Does Not Mean Low Risk
    Ibuprofen and naproxen are easy to buy, but oral NSAIDs can affect kidneys, stomach and intestinal bleeding, blood pressure, fluid balance, and cardiovascular risk. Brand combinations can conceal duplicate exposure.
  84. Difficulty Swallowing Pills: Do Not Crush First and Ask Later
    Large tablets, dry mouth, dysphagia, posture, and fear can make oral medicines difficult. Crushing, splitting, opening, or mixing a dosage form can change release, exposure, irritation, aspiration risk, and handling safety.
  85. Medication Adherence: Fix the Regimen Before Blaming the Person
    Missed or altered doses can reflect cost, complexity, adverse effects, low expected benefit, swallowing, dexterity, cognition, beliefs, depression, language, pharmacy access, or a regimen that conflicts with daily life.
  86. Drug Interactions: Check the Exact Products, Doses, and Timing
    Interactions can change drug concentration, bleeding, blood pressure, glucose, heart rhythm, sedation, kidney injury, serotonin, or treatment effectiveness. Interaction databases are alerts, not individualized diagnoses.
  87. Possible Heart Attack: Treat New Ischemic Symptoms as Time-Sensitive
    Acute coronary syndrome can present with chest pressure or discomfort, but also breathlessness, sweating, nausea, unusual weakness, or pain in the arm, jaw, back, or upper abdomen. Symptoms and electrocardiograms are not always classic.
  88. Sudden Breathlessness: Heart, Lung, Clot, Infection, and Metabolic Causes Can Overlap
    Acute breathlessness is a symptom, not a diagnosis. Pulmonary embolism, heart failure, acute coronary syndrome, pneumonia, airway disease, anemia, arrhythmia, metabolic disturbance, and anxiety can resemble or coexist with one another.
  89. Pulmonary Embolism: Use Probability Before Testing and Severity After Diagnosis
    Pulmonary embolism ranges from small clots with mild symptoms to circulatory collapse. Neither symptoms nor a single risk factor can diagnose it, and indiscriminate imaging creates false positives and burden.
  90. Possible Deep Vein Thrombosis: One-Sided Swelling Needs a Probability Pathway
    Pain, swelling, warmth, and discoloration in one limb may reflect deep vein thrombosis, but infection, injury, venous disease, lymphatic disease, heart failure, and medication edema can resemble it.
  91. Aortic Dissection and Aneurysm Rupture: Sudden Severe Pain Is an Emergency
    Acute aortic syndromes can cause sudden severe chest, back, or abdominal pain, fainting, shock, stroke-like symptoms, limb ischemia, or organ injury. Presentation is variable and delay can be fatal.
  92. Fainting Is a Symptom: Identify Cardiac and Bleeding Risk Before Calling It Vasovagal
    Syncope is a brief loss of consciousness from transient global cerebral hypoperfusion with rapid recovery. Seizure, intoxication, concussion, hypoglycemia, and psychogenic events can mimic it.
  93. Acute Heart Failure: New Breathlessness and Congestion Need Cause and Trigger
    Acute heart failure is new or worsened congestion or low output, not simply ankle swelling or one weight change. Infection, ischemia, arrhythmia, pressure, kidney injury, medicines, and missed access can precipitate it.
  94. Gastrointestinal Bleeding: Color, Volume, Physiology, and Medicines All Matter
    Vomiting blood, coffee-ground material, black tarry stool, maroon stool, or red rectal bleeding can arise from different gastrointestinal sites. Visible volume does not reliably measure total blood loss.
  95. Severe Abdominal Pain in Later Life: Do Not Miss Mesenteric Ischemia
    Acute abdominal pain can reflect benign disease, but vascular, obstructive, perforating, infectious, pancreatic, biliary, urinary, cardiac, or medication causes can deteriorate rapidly. Mesenteric ischemia becomes more likely with age and vascular risk.
  96. Sudden Vision Loss: Retinal Stroke and Detachment Cannot Wait for a Routine Visit
    Sudden painless loss in one eye can be retinal arterial ischemia—an ocular stroke—or retinal detachment and other retinal disease. Painful vision loss raises different emergencies, including acute angle closure, inflammation, infection, or trauma.
  97. Anaphylaxis: Epinephrine First, Then a Durable Emergency Plan
    Anaphylaxis is a serious systemic allergic reaction that can affect airway, breathing, circulation, skin, and gastrointestinal systems. Skin findings may be absent, and severity can escalate quickly.
  98. Hyperkalemia: Confirm the Result, Protect the Heart, Remove Potassium
    High potassium can disturb cardiac conduction and become fatal, but symptoms and ECG findings are inconsistent. Hemolyzed blood samples can create a false elevation, while a normal-looking ECG cannot guarantee safety.
  99. Heat Stroke: Confusion in the Heat Is an Emergency
    Heat illness ranges from cramps and exhaustion to heat stroke, where central nervous system dysfunction and dangerous heat exposure threaten multiple organs. Older adults may not sweat or report thirst typically.
  100. Possible Poisoning or Overdose: Call Early and Bring the Exact Product
    Medication errors, household chemicals, supplements, carbon monoxide, alcohol, and illicit or counterfeit substances create different toxic syndromes. Symptoms can be delayed, and home remedies can worsen exposure.
  101. A Chronic Wound Is a Diagnosis Problem Before It Is a Dressing Problem
    Pressure, venous hypertension, arterial ischemia, neuropathy, infection, cancer, inflammation, and trauma can produce wounds that look similar but need different treatment.
  102. Diabetes Foot Protection: Daily Inspection Is Necessary but Not Sufficient
    Neuropathy can hide injury while peripheral artery disease slows healing, so prevention combines self-checks with professional risk assessment, footwear, callus care, and rapid access.
  103. Diabetic Foot Ulcer Offloading: Healing Requires Removing Repetitive Load
    A plantar ulcer can receive excellent topical care and still fail if each step repeatedly reloads the injured tissue.
  104. Diabetes-Related Foot Infection: Antibiotics Are Only One Part of Limb Rescue
    Severity, depth, perfusion, bone involvement, drainage, source control, and offloading determine the pathway; a superficial swab and oral prescription do not answer them all.
  105. A Foot Wound With Poor Blood Flow Is a Vascular Emergency Question
    Ischemic wounds may be small yet limb-threatening; pain can be absent when neuropathy coexists, and normal-looking skin elsewhere does not prove adequate perfusion.
  106. Venous Leg Ulcers: Compression Works When the Diagnosis and Delivery Are Right
    Compression addresses venous hypertension, but safe intensity depends on arterial supply, heart status, limb shape, skin, skill, and whether the system is actually worn.
  107. Leg Swelling and Compression: Identify the Fluid Problem Before Squeezing It
    Venous edema, lymphedema, heart failure, kidney or liver disease, medication effects, thrombosis, infection, and immobility can overlap; compression is not interchangeable across them.
  108. Cellulitis: Treat Infection, but Reassess the Red-Leg Diagnosis
    Cellulitis can become dangerous, yet edema, stasis dermatitis, contact dermatitis, gout, thrombosis, and other mimics make diagnostic follow-up essential.
  109. Stasis Dermatitis: The Chronic Red-Leg Mimic That Needs Venous Care
    Itch, scaling, discoloration, and bilateral lower-leg inflammation often reflect venous hypertension, but ulceration, contact allergy, and true infection can coexist.
  110. Skin Tears in Later Life: Preserve the Flap and Prevent the Next Injury
    Fragile skin can separate after minor friction or adhesive removal; early gentle care and prevention reduce pain, tissue loss, and repeat injury.
  111. Dry, Itchy Skin in Later Life: Repair the Barrier and Check the Cause
    Xerosis is common, but generalized or persistent itch can also reflect dermatitis, infestation, medicines, kidney or liver disease, blood disorders, neuropathy, or cancer treatment.
  112. New Bruising in Later Life: Review Trauma, Skin Fragility, and Bleeding Risk
    Age-related purpura is common, but sudden, extensive, painful, patterned, or unexplained bruising can signal medication effects, platelet or clotting problems, liver disease, trauma, or abuse.
  113. A Changing Mole or Pigmented Lesion: Evolution Matters More Than a Perfect Checklist
    ABCDE features are useful prompts, but melanoma can be small, amelanotic, nail-based, acral, or simply unlike a person's other lesions.
  114. Basal and Squamous Cell Skin Cancer: A Nonhealing Spot Deserves Diagnosis
    Common keratinocyte cancers are often highly treatable, but squamous cancers can spread and location, depth, immune status, recurrence, and nerve symptoms change risk.
  115. Palliative Wound Care: Healing Is Not the Only Meaningful Outcome
    When closure is unlikely or treatment burden is unacceptable, care can still reduce pain, odor, bleeding, drainage, isolation, and caregiver strain.
  116. Lupus Care: Control Organ Inflammation While Minimizing Steroid Burden
    Systemic lupus can affect skin, joints, blood, kidney, brain, lung, heart, and pregnancy; good care separates active inflammation from damage, infection, medication toxicity, and common comorbidity.
  117. Lupus Kidney Protection: Urine Can Change Before Symptoms
    Lupus nephritis may appear through protein, blood, casts, rising creatinine, edema, or blood pressure rather than pain; scheduled surveillance enables earlier diagnosis and treatment.
  118. Sjögren's Disease: Dryness Is Only One Part of the Clinical Picture
    Dry eyes and mouth can cause corneal, dental, nutrition, sleep, and communication problems, while some people also develop neurologic, lung, kidney, joint, vascular, or lymphatic disease.
  119. Systemic Sclerosis: Raynaud, Digital Ulcers, Lung, Heart, Kidney, and Gut Need One Plan
    Skin thickening is visible, but vascular and internal-organ disease drive much of the risk; structured screening can detect complications before advanced symptoms.
  120. Autoimmune Rheumatic Disease and Interstitial Lung Disease: Track Trajectory, Not One Scan
    Rheumatoid arthritis, systemic sclerosis, inflammatory myopathy, mixed connective-tissue disease, and Sjögren's can involve the lungs, but patterns and treatment differ.
  121. Vaccination During Rheumatic Disease Treatment: Time the Protection, Not the Fear
    Vaccine response, live-vaccine safety, disease activity, age, exposure, and the exact immunomodulator shape timing; the answer is rarely to skip all vaccines.
  122. Fever During Immunosuppression: Treat It as a Time-Sensitive Diagnostic Problem
    Immunomodulators and steroids can blunt fever and inflammation, while autoimmune flares can mimic infection; neither assumption is safe without assessment.
  123. Long-Term Glucocorticoids: Prevent Harm From the First Prescription
    Steroids can be lifesaving anti-inflammatory treatment, yet fracture, infection, diabetes, muscle loss, cataract, hypertension, skin, mood, sleep, and adrenal risks begin before many patients consider therapy long term.
  124. Surgery During Antirheumatic Treatment: Build a Drug-by-Drug Perioperative Plan
    Continuing therapy can increase selected infection risks, while holding it can provoke a damaging flare; the balance depends on the drug, disease severity, operation, wound, and patient.
  125. Cardiovascular Prevention in Autoimmune Rheumatic Disease: Inflammation Is One Risk Layer
    Chronic inflammatory disease can increase cardiovascular risk, but blood pressure, lipids, smoking, diabetes, kidney disease, activity, body composition, medicines, and access still require ordinary high-quality prevention.

Open the focused topic page →

Understand the mechanisms

Biology of Aging

Hallmarks, senescence, mitochondria, epigenetics, and where laboratory biology meets uncertainty.

10 evidence articles

  1. The Twelve Hallmarks of Aging: A Map, Not a Scorecard
    The hallmarks organize interconnected biology; they are not twelve consumer problems to test and fix.
  2. Why the Hallmarks Are Not an Anti-Aging Checklist
    Targeting a mechanism in a model is not the same as proving a safe treatment in healthy people.
  3. Cellular Senescence Has Helpful and Harmful Roles
    Senescent cells stop dividing but remain active; their effects depend on cell type, timing, and context.
  4. Inflammaging: A Research Concept, Not a Diagnosis
    Chronic age-associated inflammatory patterns are real research targets, but there is no single consumer test or cleanse.
  5. Telomeres Are Biology, Not a Personal Countdown Clock
    Telomere length varies by cell type, inheritance, measurement, and life history; it does not reveal an expiration date.
  6. Mitochondria: Essential, Dynamic, and Easy to Oversell
    Mitochondria do far more than make energy, and no symptom or supplement uniquely diagnoses ‘mitochondrial aging.’
  7. Autophagy Is Cellular Housekeeping, Not a Fasting Meter
    Cells use autophagy to recycle components, but people cannot read its level from hunger or a consumer timer.
  8. Nutrient Sensing: From Conserved Pathways to Human Complexity
    mTOR, AMPK, insulin, and related pathways help cells respond to nutrients; they are not simple longevity dials.
  9. Epigenetics Does Not Mean Your Genes Are Under Total Control
    Gene regulation changes with age and environment, but epigenetics is neither destiny nor a blank slate.
  10. The Microbiome Is an Ecosystem, Not a Single Good-Bacteria Score
    Microbial communities vary with diet, geography, medicines, illness, and methods, making universal optimization claims premature.

Open the focused topic page →

Track signal, not noise

Measure What Matters

Biological clocks, functional measures, familiar clinical markers, and the limits of dashboards.

17 evidence articles

  1. Biological Age Is a Family of Models, Not One Fact
    Different clocks use different inputs and predict different outcomes; disagreement is expected.
  2. Epigenetic Clocks: Promising Research, Limited Personal Guidance
    Methylation clocks can stratify research risk while still being weak tools for individual treatment decisions.
  3. Grip Strength: Useful Signal, Incomplete Story
    Grip is quick and informative at a population level, but it reflects more than muscle alone.
  4. Walking Speed: A Vital Sign With Context
    Usual pace reflects strength, balance, joints, heart, lungs, nervous system, confidence, and environment.
  5. Chair Rise and Balance Tests: Simple, Not Self-Explanatory
    Short functional tests can reveal change, but furniture, instructions, pain, footwear, and safety affect the result.
  6. Blood Pressure Trends Beat Isolated Readings
    Repeated, well-measured averages are more useful than reacting to the highest number on the screen.
  7. LDL Cholesterol: Important Marker, Broader Decision
    LDL-related risk reflects concentration, duration of exposure, existing disease, and the rest of the cardiovascular profile.
  8. A1C and Glucose: Useful Tests With Different Windows
    Glucose tests capture different aspects of metabolism; no single result should be detached from symptoms and context.
  9. Sleep Scores Are Estimates, Not Grades
    A consumer sleep score compresses several uncertain estimates into one persuasive number.
  10. Personal Trends Can Help—If the Measurement Is Stable
    Repeated data are useful only when the method is consistent and the change is larger than noise.
  11. Screening for Atrial Fibrillation: More Detection Is Not the Same as Fewer Strokes
    Pulse checks, watches, patches, and implanted monitors can uncover silent atrial fibrillation, but the health value depends on who is screened and what follows.
  12. Coronary Artery Calcium Scanning: A Decision Aid, Not a Heart-Age Score
    CAC can refine atherosclerotic risk when preventive treatment is genuinely uncertain, but routine scanning has not been shown to improve population outcomes.
  13. Anemia in Older Adults: A Finding to Explain, Not a Normal Aging Value
    Anemia is common with age and associated with frailty and adverse outcomes, but age alone is not a mechanism. Blood loss, nutrient deficiency, inflammation, kidney disease, hemolysis, and marrow disorders require a structured evaluation.
  14. Frailty Before Surgery: Use It to Improve Decisions, Not Deny Care
    Frailty captures reduced reserve and vulnerability that age and diagnosis alone miss. It predicts complications, delirium, prolonged recovery, institutional care, and death, but it is a risk signal rather than a verdict.
  15. Red Blood Cell Transfusion After Surgery: Thresholds Need Clinical Context
    Hemoglobin concentration informs transfusion but does not measure bleeding rate, oxygen delivery, symptoms, or the expected course. Transfusion can help when anemia is clinically important and can harm when given reflexively.
  16. Kidney Function and Medication Dosing: Use the Right Estimate at the Right Time
    Kidneys clear many medicines and metabolites, but drug labels may use different filtration estimates. Low muscle mass can make creatinine-based values misleading, and acute kidney injury breaks the assumption of steady state.
  17. Monitoring a Medicine: Define the Benefit, Harm, and Decision Before Ordering Tests
    A laboratory schedule is not a monitoring plan unless each result changes a decision. Symptoms, function, technique, adherence, interactions, and disease outcomes may matter as much as numbers.

Open the focused topic page →

Explore carefully

Emerging Longevity Science

Rapamycin, senolytics, reprogramming, regenerative medicine, and the human-evidence boundary.

17 evidence articles

  1. How to Evaluate an ‘Anti-Aging’ Treatment
    Start with approval status, human evidence, meaningful outcomes, harms, and conflicts—not the pathway diagram.
  2. Rapamycin for Longevity: What Human Evidence Says in 2026
    Strong lifespan effects in model organisms have not established a proven anti-aging therapy for healthy adults.
  3. mTOR Is Not a Longevity On-Off Switch
    mTOR signaling supports growth, metabolism, immunity, and tissue function; suppressing it is not universally beneficial.
  4. Senolytics: Compelling Idea, Early Human Evidence
    Clearing selected senescent cells improves outcomes in some models; safe, effective human use for aging is not established.
  5. The Dasatinib-Plus-Quercetin Pilot: What Twelve Participants Can Tell Us
    A small single-arm study can test feasibility and generate hypotheses; it cannot establish effectiveness.
  6. Partial Cellular Reprogramming: Where the Science Actually Is
    Research has altered aging-related features in cells and animal models; rejuvenating whole healthy humans has not been demonstrated.
  7. Gene Therapy Is Real Medicine—Not a DIY Longevity Tool
    Approved gene therapies target specific serious conditions; this does not validate self-experimentation or anti-aging gene kits.
  8. Stem Cell and Exosome Clinics: Approval Before Testimonials
    A clinic, patient story, or ClinicalTrials.gov listing does not prove that a regenerative product is approved or effective.
  9. A Biomarker Win Is Not Yet a Health Win
    Changing a clock, cytokine, or pathway marker matters only if the marker is validated for the decision being claimed.
  10. What Evidence Would Make an Experimental Longevity Therapy Convincing?
    The bar is replicated randomized human benefit with acceptable harms—not a larger collection of mechanisms and testimonials.
  11. GLP-1 Drugs and Longevity: Real Outcome Benefits, Wrong Universal Claim
    Semaglutide reduced cardiovascular events in a defined high-risk population. That is important medicine, not proof that GLP-1 therapy is a general anti-aging treatment.
  12. Metformin for Longevity: The Human Evidence Is More Conditional Than the Hype
    A valuable diabetes drug remains an unproven treatment for extending healthy life in people without diabetes, with randomized studies showing context-dependent and sometimes unfavorable effects.
  13. NAD Boosters: Raising NAD Is Not the Same as Improving Healthspan
    NMN and nicotinamide riboside can change blood metabolites. Consistent improvements in strength, metabolism, cognition, or clinical outcomes have not followed.
  14. The First Larger Senolytic Trial Delivered a Necessary Reality Check
    Dasatinib plus quercetin did not improve the prespecified primary bone-resorption outcome in a phase 2 randomized trial of 60 postmenopausal women.
  15. SGLT2 Inhibitors: Powerful Organ Protection Is Not the Same as a Longevity Drug
    These medicines improve kidney and heart-failure outcomes in defined high-risk populations, including many people without diabetes, but that does not make them appropriate for healthy people seeking life extension.
  16. Multi-Cancer Detection Blood Tests: Finding a Signal Is Not Yet Saving a Life
    Multi-cancer detection tests can identify molecular signals linked to several cancers, but no completed randomized trial has shown that screening asymptomatic people reduces cancer mortality.
  17. Shingles Vaccination and Dementia: An Important Signal, Not a New Indication
    A strong natural experiment suggests zoster vaccination may reduce dementia diagnoses, but the finding involved an older live vaccine and does not yet prove that current vaccination prevents dementia.

Open the focused topic page →

Read claims clearly

Evidence Literacy

A practical guide to trials, risk, endpoints, reviews, conflicts, registries, and corrections.

54 evidence articles

  1. The Evidence Ladder Is a Shortcut—Use It Carefully
    Study design affects what can be inferred, but quality, fit, and execution matter within every rung.
  2. Association Is Not Causation—But It Is Not Meaningless
    Observational research can reveal patterns and risks; confounding and reverse causation limit causal claims.
  3. What Randomization Does—and Does Not—Fix
    Random assignment reduces allocation bias; it cannot rescue poor outcomes, missing data, bad adherence, or selective reporting.
  4. Relative Risk Can Make Small Effects Look Large
    A percentage reduction is incomplete without the starting risk, time period, and number of people affected.
  5. Surrogate Endpoints: Faster Answers, Bigger Assumptions
    A laboratory or imaging change can speed a trial only when it reliably stands in for how patients feel, function, or survive.
  6. How to Read a Systematic Review
    A review is only as trustworthy as its question, search, inclusion rules, studies, and synthesis.
  7. Heterogeneity Is Information, Not Just an I² Number
    Different people, interventions, comparators, methods, and outcomes can produce genuinely different effects.
  8. ClinicalTrials.gov Is a Map, Not a Seal of Approval
    Registration improves transparency, but listed studies can be early, uncontrolled, incomplete, or scientifically weak.
  9. Conflicts of Interest: Read Them, Do Not Stop There
    A conflict can increase risk of bias; it does not automatically falsify a result or replace method review.
  10. Why Good Health Articles Need Dates, Sources, and Corrections
    Accuracy is a maintenance practice, not a permanent badge.
  11. What Should a Geroscience Trial Actually Measure?
    Aging trials need feasible endpoints, but convenience can turn a quick biomarker change into an unsupported claim about longer, healthier life.
  12. Whole-Body MRI Screening: Many Findings, No Proven Longevity Benefit
    A scan can produce a detailed map of anatomy without showing that scanning asymptomatic, average-risk people improves survival or quality of life.
  13. Cancer Surveillance: More Scanning Is Not Automatically Better Follow-Up
    Recurrence surveillance is cancer-specific. A test is useful when it detects clinically meaningful recurrence early enough to improve decisions, with acceptable false-positive, radiation, contrast, cost, and anxiety burdens.
  14. Recurrence and Second Primary Cancer Are Different Diagnoses
    A recurrence arises from surviving cells of the original cancer; a second primary is a new cancer. Treatment exposure, inherited risk, aging, behavior, environment, and chance can affect second-cancer risk.
  15. Beers and STOPP/START Criteria: Screening Tools, Not Stop Lists
    Potentially inappropriate medication criteria flag situations where harm may outweigh benefit or useful treatment may be missing. They are prompts for clinical review, not universal bans or substitutes for an accurate diagnosis.
  16. New Symptom or Drug Effect? Use a Medication Timeline Before Adding a Diagnosis
    Fatigue, dizziness, confusion, constipation, swelling, cough, tremor, sleep change, sexual symptoms, and falls can arise from medicine, disease, interaction, withdrawal, or several causes at once.
  17. A Positive ANA Is a Clue, Not an Autoimmune Diagnosis
    Antinuclear antibodies occur in systemic autoimmune disease, but also in people without one; symptoms, pretest probability, titer, pattern, disease-specific antibodies, and objective organ findings determine meaning.
  18. Sensitivity and Specificity Describe a Test, Not Your Diagnosis
    Sensitivity asks how often a test detects disease among people who have it; specificity asks how often it is negative among people who do not. Neither directly states an individual's probability after testing.
  19. Predictive Value Changes With Prevalence: Why Rare-Disease Screening Produces False Alarms
    The same test can have a strong positive predictive value in a high-risk clinic and a poor one in healthy screening because the number of true cases underneath the test has changed.
  20. A Laboratory Reference Range Is Not the Border Between Healthy and Sick
    Reference intervals describe a selected population and method; clinical decision limits, biologic variation, measurement error, age, sex, time, food, exercise, and medicines determine interpretation.
  21. Repeat Testing and Regression to the Mean: Extreme Results Often Move Toward Average
    People often enter care or studies when symptoms or biomarkers are unusually bad; on the next measurement, random and cyclical variation can look like treatment success.
  22. Statistical Significance Is Not the Same as a Meaningful Health Benefit
    A tiny effect can be statistically convincing in a huge trial, while an important effect can remain imprecise in a small one; magnitude, uncertainty, outcome, burden, and baseline risk decide relevance.
  23. Composite Endpoints Can Hide Which Outcome Drove the Result
    A combined endpoint increases event counts, but hospitalization, biomarker progression, procedure, disability, and death do not have equal importance or treatment response.
  24. Competing Risks Change the Meaning of Long-Term Disease Probability
    A person who dies from another cause can no longer experience a later diagnosis; treating that competing event like ordinary loss to follow-up can overstate cumulative incidence.
  25. Subgroup Results: A Forest Plot Is a Hypothesis Generator Until Proven Otherwise
    Splitting a trial by age, sex, biomarker, frailty, genotype, or baseline risk creates many chances for apparent differences; separate significance in one group and not another is not proof of interaction.
  26. Noninferiority Does Not Mean Equal: Read the Margin and What Was Preserved
    A noninferiority trial asks whether a new strategy is not unacceptably worse than control by a prespecified margin, often in exchange for another advantage such as safety, convenience, cost, or access.
  27. Target Trial Emulation Improves Observational Design, but It Does Not Randomize People
    Writing the hypothetical trial protocol first can align eligibility, treatment assignment, time zero, follow-up and analysis, reducing avoidable biases in health-record studies.
  28. Mendelian Randomization Is a Causal Tool With Strong Genetic Assumptions
    Genetic variants associated with an exposure can serve as instruments, but weak instruments, pleiotropy, population structure, selection, dynastic effects, and lifetime-versus-treatment contrasts limit interpretation.
  29. Adverse-Event Tables Depend on How Researchers Looked for Harm
    Spontaneous reports, open-ended questions, symptom checklists, laboratory surveillance, adjudication, coding dictionaries, exposure duration, and withdrawal rules produce different harm counts.
  30. External Validity: Ask Who Was Missing From the Longevity Study
    A well-randomized trial can estimate an effect in its participants yet transport poorly to older, frail, multimorbid, diverse, rural, disabled, or resource-limited populations.
  31. Missing Data Can Change a Trial Result Even When Loss Looks Small
    What matters is not only how much data are missing, but why, in which arm, after which symptoms, and how unobserved outcomes could differ from observed ones.
  32. Multiplicity: More Outcomes and Analyses Create More Chances to Win
    Multiple biomarkers, doses, time points, subgroups, models, and interim looks expand the chance that at least one result appears compelling even when no true effect exists.
  33. Random Sequence Generation and Allocation Concealment Solve Different Problems
    A random sequence creates unpredictable assignments; concealment prevents recruiters from knowing the next assignment. A study can report one while failing the other.
  34. Blinding Is About Specific People, Outcomes, and Pathways—not a Single Label
    Double-blind is too vague. Participants, clinicians, caregivers, outcome assessors, adjudicators, analysts, and investigators can each know assignments, with different consequences.
  35. Intention-to-Treat Is an Analysis Principle, Not a Cure for Every Post-Randomization Problem
    Treatment discontinuation, switching, rescue therapy, death, missing outcomes, and nonadherence require a clearly defined treatment-effect question before analysis.
  36. Relative Risk Can Sound Large While Absolute Benefit Remains Small
    A relative reduction needs the untreated event rate and time horizon before it can tell a person how many events may actually be prevented.
  37. A Hazard Ratio Is Not a Percent Longer Life or a Constant Risk Reduction
    Hazards describe instantaneous event rates among people still at risk. Their ratio is not the same as a risk ratio, survival probability, median survival gain, or percent change in lifespan.
  38. A Biomarker Becomes a Surrogate Endpoint Only Within a Validated Context
    Association with disease and change during treatment do not prove that treatment effects on a marker reliably predict effects on how people feel, function, or survive.
  39. Healthy-User Bias and Confounding by Indication Can Point in Opposite Directions
    People who choose preventive behaviors often differ from nonusers, while people prescribed treatment may begin at higher risk because clinicians recognized illness.
  40. Reverse Causation and Selection Bias Can Make an Aging Risk Factor Look Protective
    Preclinical disease can change weight, activity, sleep, biomarkers, medication, and participation years before diagnosis; conditioning on survival or enrollment can further distort associations.
  41. Meta-Analysis Heterogeneity Is a Scientific Question, Not Just an I-Squared Number
    Studies can differ in participants, interventions, comparators, outcomes, follow-up, bias, and true effects. A pooled average can be precise and still fail to describe any real setting.
  42. Publication Bias, Selective Reporting, and Spin Can All Distort the Available Story
    Whole studies, particular outcomes, time points, analyses, and the language used to describe them can be selected according to whether results look favorable.
  43. Certainty of Evidence and Strength of Recommendation Are Different Judgments
    Certainty describes confidence in an effect estimate for a defined outcome; a recommendation also considers benefit-harm balance, values, resources, equity, acceptability, and feasibility.
  44. Reliability, Validity, Responsiveness, and Utility Are Different Measurement Claims
    A measure can be repeatable but wrong, valid for one purpose but not another, responsive to noise rather than health, or accurate without improving any decision.
  45. Prediction, Explanation, and Causal Intervention Are Three Different Tasks
    A variable can improve forecasts without causing the outcome, and a causal factor can add little predictive accuracy when other information already captures risk.
  46. Overfitting Makes a Prediction Model Remember Its Development Data
    Flexible algorithms, many candidate predictors, few outcome events, repeated tuning, leakage, and optimistic performance selection can fit chance patterns that disappear in new people.
  47. External Validation Is a Continuing Program, Not a One-Time Stamp
    Populations, workflows, treatments, coding, assays, devices, prevalence, and behavior differ across sites and change over time, so prediction performance is conditional and dynamic.
  48. Pragmatic and Explanatory Trials Answer Different Parts of the Treatment Question
    Trials vary along a continuum from testing benefit under optimized conditions to testing a strategy in ordinary care; pragmatic is not a synonym for uncontrolled or low quality.
  49. Cluster Randomized Trials Must Account for Group-Level Assignment and Recruitment
    Clinics, communities, facilities, households, or clinicians may be randomized while outcomes are measured in individuals, creating dependence and special selection, consent, and analysis problems.
  50. Crossover Trials Need Stable Conditions, Reversible Effects, and Credible Washout
    When participants receive multiple treatments in randomized sequences, each person can serve as their own control—but time, carryover, dropout, and unblinding can break the comparison.
  51. Factorial Trials Estimate Multiple Main Effects—but Interactions Can Change the Story
    A two-by-two factorial trial can test interventions A and B efficiently across four combinations, provided the estimands, compatibility, interaction assumptions, and analysis are clear.
  52. Adaptive and Platform Trials Are Prespecified Experiments, Not Flexible Storytelling
    Response-adaptive randomization, arm dropping, sample-size changes, enrichment, and shared controls can improve learning when rules and error control are specified before interim data are seen.
  53. Pilot Studies Test Feasibility; They Rarely Establish Treatment Benefit
    Small randomized pilots are designed to learn whether and how a definitive trial can work, not to provide a noisy preview that becomes an efficacy claim when favorable.
  54. Reproducibility Requires Transparent Decisions, Data Provenance, Code, and Independent Replication
    Repeating an analysis from shared code, reproducing a result with independent data, and replicating a finding in a new experiment are related but distinct forms of confidence.

Open the focused topic page →